文献速递母胎医学产科

胎儿房性期前收缩:自然病程、危险因素与不良结局

Fetal premature atrial contractions: natural course, risk factors and adverse outcome.
PubMed 文献 · Ultrasound Obstet Gynecol · 2024-01-01

这项回顾性队列研究纳入2007至2022年荷兰阿姆斯特丹两家学术中心确诊胎儿房性期前收缩(PAC)的939例,总不良结局发生率6.8%,快速性心律失常3.4%,先天性心脏病1.5%。PAC多可自行消退,短阵室上性心动过速等为快速性心律失常的危险因素。

要点

  • 胎儿PAC多良性且常自行消退,但需转诊行高级超声检查以分型并评估不良结局风险。
  • 存在快速性心律失常危险因素时,建议每周胎儿心率监测直至PAC消退。
  • 无危险因素时标准产科保健可能已足够,并应告知孕妇注意胎动减少。

核心结论

  • 胎儿PAC通常良性且常自行消退,但出现心律失常的胎儿应转诊行高级超声检查,重点在于对PAC分型并评估不良结局风险。
  • 识别出快速性心律失常危险因素时,建议每周胎儿心率监测直至PAC消退;无危险因素时标准产科保健可能已足够,并应额外告知孕妇报告胎动减少。
  • 若发生快速性心律失常或心力衰竭,应转回胎儿医学单元(FMU)。

研究设计与样本

  • 本研究为回顾性队列研究,纳入2007至2022年荷兰阿姆斯特丹两家学术中心诊断为胎儿PAC的病例,排除存在先天畸形及既往诊断先天性心脏病(CHD)或其他心律失常者。
  • 对M型和多普勒描记图重新分析并记录PAC频率,共1439例转诊病例中24.1%在FMU确认前PAC已消退,最终纳入939例确诊PAC病例。
  • 检查的不良结局包括:20周胎儿畸形筛查未发现的潜在CHD、快速性心律失常、其他心律失常、使用抗心律失常治疗及死亡;采用比值比(OR)分析快速性心律失常的危险因素。

主要发现

  • 939例确诊PAC病例中,总不良结局发生率为6.8%(64/939)。
  • CHD诊断14例(1.5%(95%CI,0.9-2.5%)),其中8例产前诊断、6例产后诊断;与基线相比,存在胎儿PAC时CHD发生率更高(OR,1.8(95%CI,1.0-3.3);P=0.034)。
  • 快速性心律失常产前和/或产后发生32例(3.4%),其中8例(25.0%)出现心力衰竭征象,23例(71.9%)需要抗心律失常治疗;无快速性心律失常导致胎儿或婴儿死亡。
  • 快速性心律失常的危险因素包括:PAC伴短阵室上性心动过速(OR,98.7)、阻滞性PAC(OR,30.3)、二联律PAC(OR,21.8)、频繁PAC(每5-10次心搏一次)(OR,6.9)、心力衰竭征象(OR,14.2)及卵圆孔动脉瘤(OR,5.0)。

临床怎么用

  • 作者建议,出现心律失常的胎儿应转诊行高级超声检查,重点对PAC分型并评估不良结局风险。
  • 作者建议,识别出快速性心律失常危险因素时,每周胎儿心率监测直至PAC消退。
  • 作者建议,无危险因素时标准产科保健可能已足够,并应额外告知孕妇报告胎动减少。
  • 作者建议,若发生快速性心律失常或心力衰竭,应转回FMU。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Fetal premature atrial contractions (PAC) are usually benign but may be associated with congenital heart defect (CHD) and tachyarrhythmia, which in turn carry a risk of cardiac failure and fetal death. We aimed to explore the frequency of adverse outcome and to identify risk factors for tachyarrhythmia in pregnancies complicated by fetal PAC. METHODS: This was a retrospective cohort study of fetuses diagnosed with PAC at two academic centers in Amsterdam, The Netherlands, between 2007 and 2022. Cases with a congenital anomaly and those with a prior diagnosis of CHD or other arrhythmias were excluded. M-mode and Doppler tracings were reanalyzed and the frequency of PAC was recorded. The incidence of the following adverse outcomes was examined: underlying CHD not identified at the 20-week fetal anomaly scan, tachyarrhythmia, other arrhythmia, administration of antiarrhythmic therapy and death. Risk factors for tachyarrhythmia were analyzed using odds ratios (OR). RESULTS: In 24.1% of 1439 referred cases, PAC resolved before confirmation at the fetal medicine unit (FMU). Of the 939 included cases with confirmed PAC, the total incidence of adverse outcome was 6.8% (64/939). CHD was diagnosed in 14 (1.5% (95% CI, 0.9-2.5%)) cases, of which eight were diagnosed prenatally and six postnatally. Compared with baseline, the incidence of CHD was higher in the presence of fetal PAC (OR, 1.8 (95% CI, 1.0-3.3); P = 0.034). Tachyarrhythmia occurred prenatally and/or postnatally in 32 (3.4%) cases, of which eight (25.0%) showed signs of cardiac failure, and in 23 (71.9%) cases, antiarrhythmic therapy was required. No cases of tachyarrhythmia led to fetal or infant death. Risk factors for tachyarrhythmia were PAC with short runs of supraventricular tachycardia (OR, 98.7), blocked PAC (OR, 30.3), PAC in bigeminy (OR, 21.8), frequent PAC (one per 5-10 beats) (OR, 6.9), signs of cardiac failure (OR, 14.2) and the presence of a foramen ovale aneurysm (OR, 5.0). CONCLUSIONS: PAC are generally benign and often resolve spontaneously. However, fetuses with an irregular heart rhythm should be referred for advanced ultrasonography, which should focus on classifying the type of PAC and risk of adverse outcome. When risk factors for tachyarrhythmia are identified, weekly fetal heart-rate monitoring is advised until resolution of the PAC. In the absence of risk factors, standard obstetric care may be sufficient, with additional instructions to report reduced fetal movements. Should tachyarrhythmia or cardiac failure develop, referral back to the FMU is indicated. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Bet BB, Eijsbroek FC, van Leeuwen E, et al. Fetal premature atrial contractions: natural course, risk factors and adverse outcome. Ultrasound Obstet Gynecol. 2024. PMID: 38030959. doi:10.1002/uog.27546

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。